BioPlus Acquisition Corp.
BIOSNASDAQFinancial Services
$10.80
$-0.01(-0.05%)
Market Cap$209072163
P/E Ratio—
52W High$11.68
52W Low$10.12
BioPlus Acquisition Corp. (BIOS) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BIOS · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2022-12 | 2021-12 | 2018-12 | 2017-12 | 2016-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.71B | $0.82B | $0.94B |
| Cost of Revenue | $0.00B | $0.00B | $0.47B | $0.55B | $0.67B |
| Gross Profit | ($0.00B) | $0.00B | $0.24B | $0.27B | $0.27B |
| Gross Margin %(computed) | — | — | 34.28% | 32.95% | 28.39% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B | $0.05B | $0.06B | $0.07B |
| Total Operating Expenses | $0.00B | $0.00B | $0.24B | $0.28B | $0.26B |
| Operating Income | ($0.00B) | ($0.00B) | ($0.11B) | ($0.05B) | ($0.08B) |
| Operating Margin %(computed) | — | — | -15.31% | -6.45% | -8.30% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | ($0.06B) | ($0.05B) | ($0.04B) |
| Income Before Tax | $0.00B | ($0.00B) | ($0.05B) | ($0.07B) | ($0.03B) |
| Income Tax Expense | ($0.00B) | $0.00B | $0.00B | $0.06B | $0.00B |
| Net Income | $0.01B | ($0.00B) | ($0.05B) | ($0.13B) | ($0.03B) |
| Net Margin %(computed) | — | — | -7.28% | -16.03% | -3.68% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.01 | $-0.02 | $-0.40 | $-1.06 | $-0.37 |
| Wtd Avg Shares | 0.60B | 0.00B | 0.13B | 0.12B | 0.09B |
| EBITDA | ($0.00B) | $0.00B | ($0.08B) | ($0.02B) | ($0.06B) |
| EBITDA Margin %(computed) | — | — | -11.98% | -3.06% | -6.00% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B
Explore more BioPlus Acquisition Corp. data
About BioPlus Acquisition Corp. (BIOS) Income Statement
BioPlus Acquisition Corp. (BIOS) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2022, BIOS reported revenue of $0.00B, gross profit of ($0.00B) (gross margin —), and net income of $0.01B — a net profit margin of —.
Frequently asked questions
BIOS · 4 questionsBioPlus Acquisition Corp. (BIOS) reported revenue of $0.00B for 2022, down —% year-over-year.
BIOS revenueBIOS salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09